| ANAVEX LIFE SCIENCES CORP. (AVXL) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
| Balance Sheet Date | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2021-Mar-31 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 | 2014-Mar-31 | 2013-Dec-31 | ||||||||||||||
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q2-FY2021 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 | Q1-FY2014 | ||||||||||||||
| Operating Cash Flow | (8,604,000$) | (12,464,000$) | (5,856,000$) | (12,120,000$) | (6,658,000$) | (5,180,000$) | (11,656,000$) | (7,318,000$) | (5,849,000$) | (7,653,000$) | (8,489,000$) | (5,794,000$) | (5,262,892$) | (5,725,159$) | (2,534,306$) | (7,501,184$) | (4,331,458$) | (4,160,169$) | (4,053,172$) | (2,088,134$) | (2,820,967$) | (3,620,133$) | (2,191,883$) | (2,973,980$) | (697,742$) | (3,153,626$) | (1,433,359$) | (1,430,296$) | (670,281$) | (693,070$) | (916,855$) | (960,005$) | (347,529$) | (434,990$) | |||||||||||||||
| Investing Cash Flow | 0$ | 0$ | 0$ | (688$) | 0$ | 0$ | (2,327$) | ||||||||||||||||||||||||||||||||||||||||||
| Purchases of Property and Equipment | |||||||||||||||||||||||||||||||||||||||||||||||||
| Financing Cash Flow | 10,017,000$ | (2,143,000$) | 852,000$ | 708,000$ | 89,000$ | 4,550,000$ | 7,277,000$ | 59,000$ | 2,056,000$ | 9,003,000$ | 18,334,000$ | 258,000$ | 4,367,540$ | 10,997,952$ | 3,470,730$ | 9,292,545$ | 3,074,134$ | 1,944,700$ | 1,156,218$ | 2,259,142$ | 428,907$ | 4,228,520$ | 4,838,716$ | 4,415,837$ | 2,887,849$ | 15,128,272$ | 8,763,004$ | 3,080,984$ | 0$ | 411,856$ | 0$ | (53,872$) | 9,445,160$ | 188,170$ | |||||||||||||||
| End Cash Position | 102,577,000$ | 101,164,000$ | 115,771,000$ | 120,775,000$ | 132,187,000$ | 138,756,000$ | 139,386,000$ | 143,765,000$ | 151,024,000$ | 154,817,000$ | 153,467,000$ | 143,622,000$ | 149,158,000$ | 75,859,339$ | 29,249,018$ | 26,563,071$ | 27,458,423$ | 22,185,630$ | 21,249,206$ | 19,457,845$ | 20,715,169$ | 22,930,638$ | 25,827,592$ | 25,656,584$ | 28,048,644$ | 27,440,257$ | 24,793,424$ | 23,351,567$ | 9,186,814$ | ||||||||||||||||||||
| Exchange Rate Effect | |||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid | |||||||||||||||||||||||||||||||||||||||||||||||||
| Unlevered Free Cash Flow | (8,604,000$) | (12,464,000$) | (5,856,000$) | (12,120,000$) | (6,658,000$) | (5,180,000$) | (11,656,000$) | (7,318,000$) | (5,849,000$) | (7,653,000$) | (8,489,000$) | (5,794,000$) | (5,262,892$) | (5,725,159$) | (2,534,306$) | (7,501,184$) | (4,331,458$) | (4,160,169$) | (4,053,172$) | (2,088,134$) | (2,820,967$) | (3,620,133$) | (2,191,883$) | (2,973,980$) | (697,742$) | (3,153,626$) | (1,433,359$) | (1,430,296$) | (670,281$) | (693,070$) | (916,855$) | (960,005$) | (347,529$) | (434,990$) | |||||||||||||||